HYPD
HYPERION DEFI, INC.
NASDAQ · Healthcare · Medical - Devices · US
$3.92
+12.97%Year over year
Reported trailing growth
- Revenue
- +3052.0%
- EBITDA
- +29.0%
- EBIT
- +59.8%
- EPS
- +93.3%
- Free cash flow
- +18.3%
- Operating cash flow
- +29.6%
Forward estimates
Based on analyst estimates
- Revenue
- +522.3%
- EBITDA
- —
- EPS
- +279.7%
Three-year CAGR
- Revenue
- +1365.6%
- EBITDA
- +5.3%
- EBIT
- +61.1%
- Net income
- +9.0%
- EPS
- +84.3%
- Free cash flow
- +51.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026